January 4, 2018 / 7:14 AM / 2 months ago

BRIEF-Abivax To Initiate Long-Term Extension Study Of Abx464

Jan 4 (Reuters) - ABIVAX SA:

* ABIVAX TO INITIATE LONG-TERM EXTENSION STUDY OF ABX464 IN PATIENTS WITH ULCERATIVE COLITIS

* PROTOCOL AUTHORIZED BY BELGIAN AUTHORITIES, ETHICS COMMITTEE

* ULCERATIVE COLITIS PATIENTS RESPONDING TO ABX464 TO BE RECRUITED INTO 12-MONTH EXTENSION STUDY

* APPROVAL BASED ON SAFETY OBSERVED IN LONG-TERM PRECLINICAL STUDIES Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below